ABOUT THIS EPISODE

The safety and efficacy of therapeutic drugs still requires improvement. However, the advent of both systems biology and precision medicine has stimulated a rethink on the process of therapeutic drug design and polypharmacology.

More recently, the definition of polypharmacology has morphed to represent therapeutic drugs that have been designed deliberately for multi-targeting that affords beneficial effects to the patient.

This emerging effort has been labelled ‘Systems Pharmacology’ and the products are referred to as multi-target or systems pharmacology drugs.

This episode is part 2 of 2 episodes and goes into more detail on systems pharmacology, going through definitions, combination therapy vs systems pharmacology drugs, implementation and approaches.

Original article by Dr Kirkwood A. Pritchard Jr, Dr Dustin P. Martin and Dr Stephen Naylor

If you'd like to view the original article then follow the link below:

https://www.ddw-online.com/therapeutics/p322783-perspective-on-systems-pharmacology:-when-multi-targeting-is-advantageous.html

You can also download the original article pdf here:

https://www.ddw-online.com/media/32/135186/(4)-perspective-on-systems.pdf

For more information on Drug Discovery World, head to:

https://www.ddw-online.com

English
United States

TRANSCRIPT

Disclaimer: The podcast and artwork embedded on this page are from Drug Discovery World (DDW), which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

EDIT

Thank you for helping to keep the podcast database up to date.